CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Grant or award President and CEO acquired 11,549 shares (grant or award)
- 4 Open-market sale SVP, Chief Medical Officer sold 2,617 shares at $5.32 ($13,928)
- 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 5,284 shares at $5.25 ($27,762)
- 4 Open-market sale VP, Fin. and Admin., CFO sold 2,537 shares at $5.51 ($13,966)
- 4 Open-market sale Sr. VP, Drug Development sold 18,270 shares at $5.23 ($95,552)
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Sr. VP, Business & Comm. Dvp. acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,440,923 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 24,264 shares at $3.64 ($88,411)
- 4 Open-market buy Director bought 75,736 shares at an average $3.64 ($275,505)
- 4 Open-market buy SVP, Chief Medical Officer bought 3,514 shares at an average $2.93 ($10,288)
- 4 Open-market sale Sr. VP, Chief Comm. Officer sold 4,000 shares at $3.21 ($12,840)
- 4 Grant or award Director acquired 7,722 shares (grant or award)
- 4 Grant or award Director acquired 3,861 shares (grant or award)
- 4 Grant or award Director acquired 15,444 shares (grant or award)
- 4 Grant or award Director acquired 15,444 shares (grant or award)
- 4 Open-market buy Director bought 67,541 shares at an average $3.90 ($263,208)
Page 23 of 29 · 564 filings